TORSELLO, ANTONIO BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 18.300
AS - Asia 9.560
EU - Europa 7.819
SA - Sud America 1.271
AF - Africa 230
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 16
Totale 37.214
Nazione #
US - Stati Uniti d'America 17.566
SG - Singapore 3.065
IT - Italia 2.075
CN - Cina 2.048
VN - Vietnam 1.748
HK - Hong Kong 1.165
DE - Germania 1.112
RU - Federazione Russa 1.039
BR - Brasile 953
SE - Svezia 681
IE - Irlanda 644
UA - Ucraina 633
CA - Canada 611
GB - Regno Unito 415
IN - India 315
FR - Francia 303
FI - Finlandia 250
BD - Bangladesh 240
AT - Austria 161
KR - Corea 139
ID - Indonesia 132
TR - Turchia 126
AR - Argentina 108
IQ - Iraq 104
NL - Olanda 92
ZA - Sudafrica 75
PL - Polonia 73
ES - Italia 69
JP - Giappone 69
MX - Messico 69
CO - Colombia 64
BE - Belgio 56
PK - Pakistan 55
DK - Danimarca 54
SA - Arabia Saudita 54
EC - Ecuador 49
PH - Filippine 43
CH - Svizzera 38
UZ - Uzbekistan 35
MY - Malesia 32
CL - Cile 26
KE - Kenya 26
BG - Bulgaria 25
MA - Marocco 25
TN - Tunisia 23
VE - Venezuela 23
NP - Nepal 20
CZ - Repubblica Ceca 18
EG - Egitto 18
LB - Libano 18
PY - Paraguay 16
TH - Thailandia 16
JO - Giordania 15
AU - Australia 14
EU - Europa 14
TW - Taiwan 14
ET - Etiopia 13
IR - Iran 13
JM - Giamaica 13
LT - Lituania 13
OM - Oman 13
PE - Perù 13
RO - Romania 13
PS - Palestinian Territory 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 10
IL - Israele 10
KZ - Kazakistan 10
AL - Albania 9
AZ - Azerbaigian 9
PT - Portogallo 9
DZ - Algeria 8
BO - Bolivia 7
HN - Honduras 7
HU - Ungheria 7
KG - Kirghizistan 7
SN - Senegal 7
EE - Estonia 6
NG - Nigeria 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
RS - Serbia 5
SC - Seychelles 5
HR - Croazia 4
LY - Libia 4
NZ - Nuova Zelanda 4
GE - Georgia 3
GR - Grecia 3
MN - Mongolia 3
NI - Nicaragua 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CD - Congo 2
CM - Camerun 2
GA - Gabon 2
GH - Ghana 2
Totale 37.175
Città #
Ann Arbor 2.635
Singapore 1.810
Ashburn 1.592
Woodbridge 1.350
Fairfield 1.171
Hong Kong 1.144
Houston 939
Chandler 917
San Jose 836
Wilmington 834
Frankfurt am Main 763
Milan 659
Dublin 613
Jacksonville 583
Seattle 559
Ho Chi Minh City 515
Hanoi 424
New York 402
Beijing 400
Toronto 360
Cambridge 356
Dearborn 345
Santa Clara 290
Chicago 275
Princeton 260
Los Angeles 258
Dallas 243
Hefei 231
The Dalles 184
Nanjing 156
Vienna 140
Council Bluffs 135
Lauterbourg 129
Seoul 129
Rome 128
Lawrence 112
Helsinki 110
Shanghai 110
Buffalo 109
Jakarta 107
Moscow 106
Boardman 100
Altamura 98
Lachine 97
São Paulo 96
Da Nang 67
London 65
Guangzhou 64
Haiphong 61
San Diego 59
Detroit 58
Tokyo 52
Munich 51
Brussels 50
Nanchang 48
Falls Church 47
Orem 45
Baghdad 44
Nuremberg 42
Kent 41
Warsaw 40
Pune 38
Rio de Janeiro 38
Andover 37
Hebei 37
Denver 36
Biên Hòa 34
Changsha 34
Columbus 33
San Francisco 33
Tashkent 33
Brooklyn 31
Fremont 31
Mountain View 31
Poplar 31
Shenyang 31
Atlanta 30
Grafing 30
Dong Ket 29
Monza 29
Johannesburg 28
Stockholm 28
Huizen 27
Philadelphia 26
Phoenix 26
Turin 26
Ha Long 25
Montreal 25
Salt Lake City 25
Tianjin 25
Can Tho 24
Turku 24
Elora 23
Hải Dương 23
Jinan 23
Ankara 22
Hangzhou 22
Jiaxing 22
Quận Bình Thạnh 22
Zurich 22
Totale 24.758
Nome #
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 532
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 514
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 514
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 502
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 464
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 459
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 448
Growth hormone secretagogues and the regulation of calcium signaling in muscle 448
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 397
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 394
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 394
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 376
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 368
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 355
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 348
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 343
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 340
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 339
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 331
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 322
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 315
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 308
Feeding behavior during long-term hexarelin administration in young and old rats 306
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 306
Intrarticular cytokines and resolvin after ACL and meniscal tear in skeletally immature patients 306
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 306
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 305
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 303
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 298
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 297
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 296
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 295
Ghrelin in gastroenteric pathophysiology 292
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 289
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 288
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 288
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 284
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 283
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 283
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 282
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 281
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 280
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 279
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 275
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 274
TLQP-21 modulate inflammation and fibrosis in a model of ards 273
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 272
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections? 272
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 272
Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis 272
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 270
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 267
Ghrelin regulates proliferation and differentiation of osteoblastic cells. 265
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): recommendations from Italian scientific societies, patient associations and regulators 263
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 263
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 258
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 255
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 254
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 254
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 253
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 252
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 252
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 251
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 251
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 248
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 248
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 247
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 247
Somatotropic dysregulation in old mammals 246
Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy 245
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 245
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 244
Somatostatin Withdrawal as Generator of Pulsatile GH Release in the Dog: A Possible Tool to Evaluate the Endogenous GHRH Tone? 243
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection 242
Androgen therapy in neurodegenerative diseases 240
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 239
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 236
Growth hormone-inhibiting activity of cortistatin in the rat 235
Farmacologia endocrina 235
Progressive seizure aggravation in the repeated 6-Hz corneal stimulation model is accompanied by marked increase in hippocampal p-ERK1/2 immunoreactivity in neurons 235
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 232
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 232
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 228
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 228
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 226
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 226
Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic? 225
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results 224
The role of androgens in women's health and wellbeing 224
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 223
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 222
Steroids and tissue-specific modulation of galanin gene expression in the male rat reproductive system 221
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 221
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 220
Ghrelin expression in gut endocrine growths 219
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 218
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 218
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 218
Regulation of galanin by dexamethasone in the rat anterior pituitary and the uterus 217
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 216
Totale 28.809
Categoria #
all - tutte 117.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.905 149 182 233 139 100 178 85 70 109 172 152 336
2022/20233.507 375 937 375 361 290 505 43 184 211 38 109 79
2023/20242.045 75 91 93 103 281 500 419 74 132 34 38 205
2024/20255.037 270 458 361 309 429 236 360 267 333 692 401 921
2025/202613.601 1.812 1.058 972 1.394 1.451 680 1.792 618 1.149 1.048 797 830
2026/2027108 108 0 0 0 0 0 0 0 0 0 0 0
Totale 37.810